Institute of Virology, Vaccines and Sera - Torlak, Department of Research and Development, Belgrade, Serbia.
Immunol Invest. 2010;39(8):781-95. doi: 10.3109/08820139.2010.497831. Epub 2010 Aug 18.
IgM is the first antibody produced during the immune response to infection or immunization, and it can be secreted as pentamer (containing a small polypeptide, termed as J chain) or hexamer (lacking J chain). In this paper we have analyzed structural characteristics (by electrophoresis and immunoblot) and anti-bacterial specificity (by enzyme-linked immunosorbent assay) of IgM antibodies purified from female patients suffering from recurrent bacterial infections of lower urinary tract and therapeutically immunized with the mixture of heat-inactivated uropathogenic bacteria. We report on changes in the composition of IgM polymers in tested patients. The immunization induced the raise of the levels of hexamers in patients that did not respond to immunization (non-responders), while the IgM polymers remained on the pentameric level in immunization dependent responders. We propose that the composition of IgM polymers could influence the immunization outcome and should be taken in count regarding the treatment of recurrent bacterial infections.
IgM 是感染或免疫应答过程中产生的第一种抗体,它可以以五聚体(含有一种小的多肽,称为 J 链)或六聚体(缺乏 J 链)的形式分泌。在本文中,我们分析了从患有复发性下尿路感染的女性患者中纯化的 IgM 抗体的结构特征(通过电泳和免疫印迹)和抗细菌特异性(通过酶联免疫吸附试验),这些患者接受了经热灭活的尿路致病性细菌混合物的治疗性免疫。我们报告了在测试患者中 IgM 聚合物组成的变化。免疫接种诱导了未对免疫接种产生反应的患者(无反应者)中六聚体水平的升高,而在免疫依赖应答者中 IgM 聚合物仍保持在五聚体水平。我们提出,IgM 聚合物的组成可能会影响免疫接种的结果,并且在治疗复发性细菌感染时应考虑到这一点。